Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Share-based Compensation (2022 - 2023)

Historic Share-based Compensation for Therapeutics (LENZ) over the last 2 years, with Q4 2023 value amounting to $518000.0.

  • Therapeutics' Share-based Compensation fell 8569.85% to $518000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $5.7 million, marking a year-over-year decrease of 5813.51%. This contributed to the annual value of $6.4 million for FY2024, which is 37393.89% up from last year.
  • According to the latest figures from Q4 2023, Therapeutics' Share-based Compensation is $518000.0, which was down 8569.85% from $2.2 million recorded in Q3 2023.
  • Therapeutics' Share-based Compensation's 5-year high stood at $3.6 million during Q4 2022, with a 5-year trough of $142000.0 in Q1 2023.